Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis

This study has been completed.
PD Dr. Joachim Riethmöller, Tübingen
PD Dr. Assen Koitschev, Tübingen
Dr. Gerlind Schneider
Information provided by (Responsible Party):
PD Dr. Jochen G. Mainz, University of Jena Identifier:
First received: December 13, 2005
Last updated: December 3, 2014
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2006
  Primary Completion Date: May 2006 (Final data collection date for primary outcome measure)